COGNITION THERAPEUTICS, INC.

Analyst Reco. Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-27 EDT			5-day change	1st Jan Change
1.67 ^USD	-1.76%		-18.14%	-9.73%

06-07	Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target	MT
05-29	HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target	06-07	MT
HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target	05-29	MT
Ladenburg Thalmann Cuts Cognition Therapeutics' Price Target to $6 From $10, Keeps Buy Rating	23-08-14	MT
B. Riley Cuts Cognition Therapeutics' PT to $5 From $15, Notes Near-Term Dilution, Expanding R&D Efforts to Execute on Phase II/III Programs; Keeps Buy Rating	23-04-06	MT
Oppenheimer Adjusts Cognition Therapeutics Price Target to $9 From $18, Maintains Outperform Rating	22-11-15	MT
Cantor Fitzgerald Starts Cognition Therapeutics at Overweight With $12 Price Target	22-09-29	MT
Ladenburg Thalmann Starts Cognition Therapeutics at Buy With $10 Price Target	22-04-22	MT
B. Riley Lowers Cognition Therapeutics' PT to $15 from $20, Keeps Buy Rating	22-04-01	MT
Oppenheimer Adjusts Cognition Therapeutics' Price Target to $18 From $22, Maintains Outperform Rating	22-03-31	MT
B. Riley Lowers Cognition Therapeutics' Price Target to $20 from $27 After Revising Cost Capital Assumptions, Keeps Buy Rating	22-01-24	MT
Oppenheimer Starts Cognition Therapeutics at Outperform with $22 PT On Potential Offered By Lead Dementia Drug Candidate CT1812	21-11-03	MT
B. Riley Starts Cognition Therapeutics at Buy with $27 PT, Notes Conviction in Proprietary, Mid-Stage Pipeline	21-11-03	MT
Oppenheimer Starts Cognition Therapeutics at Outperform with $22 Price Target	21-11-03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer